Detection of hemophagocytic extremely multinucleated giant plasma cells after rituximab/low-dose lenalidomide treatment in CD20+ multiple myeloma

Leuk Lymphoma. 2019 Sep;60(9):2331-2333. doi: 10.1080/10428194.2019.1571200. Epub 2019 Feb 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antigens, CD20 / immunology
  • Antigens, CD20 / metabolism
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biopsy
  • Bone Marrow / pathology
  • Dose-Response Relationship, Drug
  • Giant Cells / drug effects*
  • Humans
  • Lenalidomide / administration & dosage
  • Lenalidomide / adverse effects
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / immunology
  • Multiple Myeloma / pathology
  • Plasma Cells / drug effects*
  • Rituximab / administration & dosage
  • Rituximab / adverse effects

Substances

  • Antigens, CD20
  • Rituximab
  • Lenalidomide